Camp4 Therapeutics

CAMPNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$265.940 M

$4.24 -5.78%

Close of 7 Aug 2026

Revenue

$3.50M

#3356 by revenue

Earnings

-$80.4M

Loss-making

Shares outstanding

51,919,321

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#246AdageneADAG$271.5M
#247Entrada TherapeuticsTRDA$267.5M
#248Camp4 TherapeuticsCAMP$265.9M
#249ProQR TherapeuticsPRQR$264.6M
#250Cartesian TherapeuticsRNAC$260.0M

Where these numbers come from

Share counts and financials for Camp4 Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.